BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23716050)

  • 1. Theaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.
    Isaacs CE; Xu W
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3806-14. PubMed ID: 23716050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus.
    Isaacs CE; Xu W; Merz G; Hillier S; Rohan L; Wen GY
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5646-53. PubMed ID: 21947401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
    Isaacs CE; Wen GY; Xu W; Jia JH; Rohan L; Corbo C; Di Maggio V; Jenkins EC; Hillier S
    Antimicrob Agents Chemother; 2008 Mar; 52(3):962-70. PubMed ID: 18195068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of theaflavin digallate against herpes simplex virus type 1.
    de Oliveira A; Prince D; Lo CY; Lee LH; Chu TC
    Antiviral Res; 2015 Jun; 118():56-67. PubMed ID: 25818500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lipid-peptide microbicide inactivates herpes simplex virus.
    Isaacs CE; Jia JH; Xu W
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3182-4. PubMed ID: 15273146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of black tea extract on herpes simplex virus-1 infection of cultured cells.
    Cantatore A; Randall SD; Traum D; Adams SD
    BMC Complement Altern Med; 2013 Jun; 13():139. PubMed ID: 23777309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of herpes simplex virus clinical isolates by using a combination microbicide.
    Isaacs CE; Rohan L; Xu W; Jia JH; Mietzner T; Hillier S
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1063-6. PubMed ID: 16495269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of electrolytes on virus inactivation by acidic solutions.
    Nishide M; Tsujimoto K; Uozaki M; Ikeda K; Yamasaki H; Koyama AH; Arakawa T
    Int J Mol Med; 2011 Jun; 27(6):803-9. PubMed ID: 21468540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide.
    Cardozo FT; Larsen IV; Carballo EV; Jose G; Stern RA; Brummel RC; Camelini CM; Rossi MJ; Simões CM; Brandt CR
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2541-9. PubMed ID: 23507287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inactivation of herpes simplex virus by a biological response modifier, PSK.
    Monma Y; Kawana T; Shimizu F
    Antiviral Res; 1997 Aug; 35(3):131-8. PubMed ID: 9298752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine.
    Piret J; Roy S; Gagnon M; Landry S; Désormeaux A; Omar RF; Bergeron MG
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2933-42. PubMed ID: 12183250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.
    Chamoun-Emanuelli AM; Bobardt M; Moncla B; Mankowski MK; Ptak RG; Gallay P; Chen Z
    Antimicrob Agents Chemother; 2014; 58(2):687-97. PubMed ID: 24217696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
    Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
    Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate.
    de Oliveira A; Adams SD; Lee LH; Murray SR; Hsu SD; Hammond JR; Dickinson D; Chen P; Chu TC
    Food Chem Toxicol; 2013 Feb; 52():207-15. PubMed ID: 23182741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers.
    Luganini A; Nicoletto SF; Pizzuto L; Pirri G; Giuliani A; Landolfo S; Gribaudo G
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3231-9. PubMed ID: 21576438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
    J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus virucidal activity of MST-312 and epigallocatechin gallate.
    Pradhan P; Nguyen ML
    Virus Res; 2018 Apr; 249():93-98. PubMed ID: 29604359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
    Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
    Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
    Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
    Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.